Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q2 2023 Dermatology Update

Skip to the end of the Expertise Menu

Q2 2023 Dermatology Update

The dermatology space continued to see sustained deal flow in the second quarter, even in the face of slowing M&A activity within the broader private markets. Transaction activity has been particularly concentrated in highly fragmented markets, such as California, as strategic acquirors continue to execute on their respective growth playbooks. Provident expects the lending environment to improve towards the latter half of the year, which will eventually translate to more deal activity and more seller friendly deal terms.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/07/Q2-2023-Newsletter-Package_Derm.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]